Skip to content


  • Poster presentation
  • Open Access

Detection of fusidic acid resistance determinants among Staphylococcus aureus isolates causing skin and soft tissue infections from a tertiary care centre in Chennai, South India

  • 1Email author,
  • 2,
  • 1,
  • 2 and
  • 1
BMC Infectious Diseases201212 (Suppl 1) :P45

  • Published:


  • Staphylococcus Aureus
  • Cefoxitin
  • Methicillin
  • Soft Tissue Infection
  • Tertiary Hospital


Fusidic acid (FA)- an inhibitor of protein synthesis has been used for treating superficial and some systemic infections caused by Staphylococcus aureus. Fusidic acid resistance in S. aureus has been reported throughout the world with prevalence ranging from 0.5% to 50% and is due to i) point mutation in bacterial fusA or fusE gene and ii) by acquired FA resistance determinants fusB, C and D. Indian report of fusidic acid resistant S. aureus (FRSA) is based on phenotypic detection. Hence, this study was done to detect acquired FA resistance determinants.


The study included 54 isolates of S. aureus collected from skin infections between Jan to Mar 2011 from a tertiary hospital in Chennai. MRSA was screened by cefoxitin disc diffusion method and PVL-MRSA detection was done by multiplex-PCR. FA resistance was screened by disc diffusion method and acquired resistance determinants were detected by multiplex-PCR.


Of the 54 S. aureus isolates, 32(59.2%) were found to be MRSA. A total of 13(24.1%) isolates were found to carry pvl gene of which 4 were MRSA. Two of the 54(3.7%) isolates were found to be FRSA and harbored fusC gene. Both FRSA isolates were from non-hospitalized patients and they were using FA for topical treatment.


We report for the first time in India the presence of acquired FA resistant determinant fusC gene in community isolate of methicillin susceptible S. aureus. Indiscriminate use of FA needs to be avoided to prevent the emergence of FRSA.

Authors’ Affiliations

Dept. of Microbiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai, 600113, India
Rajiv Gandhi Govt. General Hospital and Madras Medical College, Chennai, 600003, India


© Nagarajan et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.